Vertex Pharmaceuticals Inc
XETRA:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XETRA:VX1
|
US |
|
C
|
Costco Wholesale Corp
DUS:CTO
|
US |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
H
|
Haleon PLC
SWB:H6D0
|
UK |
|
N
|
NEC Corp
F:NEC1
|
JP |
|
Benefit Systems SA
F:3ZV
|
PL |
|
J
|
J B Hunt Transport Services Inc
F:JB1
|
US |
|
M
|
Morgan Stanley
XHAM:DWD
|
US |
|
Evolution AB (publ)
OTC:EVGGF
|
SE |
|
H
|
Henkel AG & Co KGaA
DUS:HEN3
|
DE |
|
M
|
Man Group PLC
OTC:MNGPF
|
UK |
|
P
|
Paychex Inc
LSE:0KGE
|
US |
|
C
|
Comcast Corp
DUS:CTP2
|
US |
|
Phillips 66
NYSE:PSX
|
US |
|
A
|
Alibaba Group Holding Ltd
BMV:BABAN
|
HK |
|
NTT Inc
OTC:NTTYY
|
JP |
|
Red River Bancshares Inc
NASDAQ:RRBI
|
US |
|
M
|
Mitsubishi Chemical Holdings Corp
OTC:MTLHY
|
JP |
|
Butterfly Network Inc
NYSE:BFLY
|
US |
|
C
|
Carrefour SA
DUS:CAR
|
FR |
|
A
|
Air China Ltd
OTC:AICAF
|
CN |
|
T
|
Teledyne Technologies Inc
F:TYZ
|
US |
|
N
|
Northrop Grumman Corp
F:NTH
|
US |
|
O
|
Ollie's Bargain Outlet Holdings Inc
F:OL6
|
US |
Dividends
Dividend Yield
Vertex Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Vertex Pharmaceuticals Inc
VX1 have decreased by 0%.
Payout Ratio
Vertex Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for VX1 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
VX1 Price
Vertex Pharmaceuticals Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown |
N/A
|
| Market Capitalization | 132.3B EUR |
| Shares Outstanding | 392 556 105 |
| Percentage of Shares Shorted |
N/A
|
